Fusion Antibodies

Fusion Antibodies, a pharmaceutical contract research company with its headquarters in Belfast, said revenue continued to grow in the six months to th(...)

Northern Ireland contract research company Fusion Antibodies recorded a 19 per cent fall in full year revenues to £2.2 million on the back of a weak f(...)

Belfast-based Fusion Antibodies said its performance in the second half of the year ended March 31st improved as orders and revenues significantly inc(...)

Northern Ireland contract research company Fusion Antibodies warned that revenues for the year ended March 31st would be “materially below current mar(...)

Losses at Belfast pharmaceutical company Fusion Antibodies quadrupled in the six months ended September 30th compared with the same period last year, (...)

Fusion Antibodies, the Northern Ireland contract research company, has reported losses of nearly £700,000 (€781,000) for its maiden year as an AIM-lis(...)

Fusion Antibodies, the Belfast-based contract research organisation, has issued a profit warning after it disclosed that trading for the current finan(...)

Belfast pharmaceutical company Fusion Antibodies said it expects revenues for the trading year ended March 31st 2018 to grow at least 40 per cent on t(...)

Belfast pharma company Fusion Antibodies has raised £5.5 million (€6.2m) in its debut on the junior market of the London Stock Exchange. Fusion, a c(...)

Embo Medical Embo Medical has created a new medical device which makes embolization procedures faster and less expensive while also offering mo(...)